Podcast: Jin Kim on the Future of Clinical Trial Operations

We’re excited to share that our CEO & Founder, Jin Kim, recently joined Chris Conner on the cc: Life Science podcast to discuss a critical question in biotech today:
How can teams finish clinical trials faster without sacrificing data integrity?

In the episode titled “Beat the Clock: Finish Clinical Trials Faster,” Jin shares how Miracle helps clinical teams eliminate bottlenecks by unifying siloed systems into one real-time dashboard. For some trials, that’s meant finishing 3-4 months ahead of schedule, protecting both timelines and budgets.

"AI is only as good as the data it has access to. And in clinical trials, that data is often siloed or messy. That’s why Miracle focuses first on building the right data infrastructure."
- Jin Kim, CEO of Miracle

Jin also reflects on Miracle’s origin story, from MIT grad school idea to a platform now supporting global Phase 1–3 trials across rare disease, CNS, cardiovascular, and more.

‍

🔍 What You’ll Learn:

• Why Excel still dominates (and impedes) clinical trial workflows
• How Miracle connects fragmented systems into one unified view
• The operational cost of waiting for weekly reports
• How enrollment funnel data can surface risks early
• What non-technical users (researchers, clinical operations, medical) actually need in clinical dashboards
• AI at AWS Life Sciences: Hype, reality, and what’s next for pharma

🎧 Listen to the full episode here:

Beat the Clock: Finish Clinical Trials Faster – cc: Life Science